Twin Tree Management
VRTX icon

Twin Tree Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Twin Tree Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.36M Sell
12,000
-3,400
-22% -$1.59M 0.11% 208
2025
Q4 		$6.98M Sell
15,400
-14,600
-49% -$6.29M 0.06% 397
2025
Q3 		$11.7M Sell
30,000
-78,100
-72% -$32.6M 0.05% 438
2025
Q2 		$48.1M Buy
+108,100
New +$49.8M 0.09% 220
2025
Q1 		– Sell
-70,500
Closed -$28.4M – 1962
2024
Q4 		$28.4M Buy
70,500
+63,000
+840% +$29.2M 0.05% 343
2024
Q3 		$3.49M Buy
+7,500
New +$3.6M 0.01% 1011
2024
Q2 		– Sell
-27,700
Closed -$11.6M – 1679
2024
Q1 		$11.6M Sell
27,700
-65,900
-70% -$27.9M 0.03% 596
2023
Q4 		$38.1M Buy
+93,600
New +$34.6M 0.07% 270
2022
Q4 		– Sell
-1,900
Closed -$550K – 1560
2022
Q3 		$550K Buy
+1,900
New +$547K ﹤0.01% 1117
2022
Q1 		– Sell
-100
Closed -$22K – 1939
2021
Q4 		$22K Buy
+100
New +$19.4K ﹤0.01% 1505
2021
Q2 		– Sell
-700
Closed -$150K – 1633
2021
Q1 		$150K Hold
700
– – ﹤0.01% 1159
2020
Q4 		$165K Sell
700
-146,700
-100% -$33.7M ﹤0.01% 1115
2020
Q3 		$40.1M Buy
+147,400
New +$40.7M 0.17% 133
2018
Q2 		– Sell
-4,200
Closed -$685K – 1365
2018
Q1 		$685K Sell
4,200
-500
-11% -$81.7K 0.01% 739
2017
Q4 		$704K Buy
4,700
+3,900
+488% +$577K 0.01% 764
2017
Q3 		$122K Buy
+800
New +$120K ﹤0.01% 851
2014
Q4 		– Sell
-700
Closed -$79K – 1203
2014
Q3 		$79K Buy
+700
New +$66.6K ﹤0.01% 908

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Twin Tree Management's VRTX Position: Q1 2026 in Review

Twin Tree Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 7,769 shares worth $3.47M. The stake represents 0.07% of the portfolio and ranks #309 among its holdings. This is a return to the name: Twin Tree Management previously reported a position in VRTX as recently as Q1 2025.

Twin Tree Management first reported a position in VRTX in Q3 2017 and has held it in 26 quarters since. The position peaked at $52.8M in Q4 2023. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Twin Tree Management held 7,769 shares of Vertex Pharmaceuticals worth $3.47M as of Q1 2026.
  • Vertex Pharmaceuticals was a new Twin Tree Management position in Q1 2026.
  • Vertex Pharmaceuticals made up 0.07% of Twin Tree Management's portfolio in Q1 2026, its #309 holding.
  • Twin Tree Management first reported a position in Vertex Pharmaceuticals in Q3 2017 and has held it in 26 quarters since.
  • Twin Tree Management's Vertex Pharmaceuticals position peaked at $52.8M in Q4 2023.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Twin Tree Management's 13F filing for Q1 2026, filed 14 May 2026.